Roivant Sciences secures $5.2B for advancing late-stage drugs like IMVT-1402 & brepocitinib. Click here to read an analysis ...

Roche AG has become the latest pharmaceutical company to respond to the Trump administration’s threat to impose tariffs, saying it will invest $50 billion in drug and diagnostics manufacturing in the ...

Invivyd secures $30M loan facility from Silicon Valley Bank in three $10M tranches, ahead of FDA discussions about Covid-19 antibody VYD2311 ...

Wells Fargo cut United Parcel Service, Inc. UPS price target from $120 to $98. Wells Fargo analyst Christian Wetherbee ...

Analysts have been eager to weigh in on the Materials sector with new ratings on BASF SE (BASFY – Research Report) and Alumis Inc. (ALMS – ...

H.C. Wainwright lowered the firm’s price target on Alumis (ALMS) to $14 from $15 and keeps a Buy rating on the shares. The firm cites ...

An ivonescimab-chemotherapy combination succeeded in a study in China. Elsewhere, the FDA asked Novavax for more COVID vaccine data and Regeneron boosted its manufacturing capabilities.

Alumis Inc., a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with ...